News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022
News Daily News No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows Todd Neale December 29, 2022
News Daily News CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults Michael O'Riordan December 28, 2022
News Daily News Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review Todd Neale December 28, 2022
News Daily News ‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD Yael L. Maxwell December 27, 2022
News Daily News Top General Cardiology and Prevention News of 2022 Michael O'Riordan December 26, 2022
News Daily News Anatomic Disease After PCI Linked With Worse Outcomes: VA CART Michael O'Riordan December 22, 2022
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News AHA Weighs in on Risks of Noncardiac Surgery in Congenital HD Patients Yael L. Maxwell December 21, 2022
News Daily News ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA Todd Neale December 16, 2022
News Daily News Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action Yael L. Maxwell December 16, 2022
News Daily News Not Just Hot, but Also Cold Weather Extremes Linked to More CV Deaths Caitlin E. Cox December 15, 2022
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says L.A. McKeown December 14, 2022
News Daily News Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs Michael O'Riordan December 13, 2022
News Daily News Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research Yael L. Maxwell December 12, 2022
News Daily News Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients Caitlin E. Cox December 09, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022